These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial. Thaçi D; Blauvelt A; Reich K; Tsai TF; Vanaclocha F; Kingo K; Ziv M; Pinter A; Hugot S; You R; Milutinovic M J Am Acad Dermatol; 2015 Sep; 73(3):400-9. PubMed ID: 26092291 [TBL] [Abstract][Full Text] [Related]
9. Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. Dowdy MJ; Nigra TP; Barth WF Arthritis Rheum; 1989 Mar; 32(3):343-6. PubMed ID: 2649111 [TBL] [Abstract][Full Text] [Related]
11. [Induction of subacute cutaneous lupus erythematosus by psoralen UV-A therapy]. Neumann C Z Hautkr; 1987 Nov; 62(21):1523-4, 1527-8. PubMed ID: 3424898 [TBL] [Abstract][Full Text] [Related]
12. Coexistent psoriasis and lupus erythematosus treated with alefacept. Berthelot C; Nash J; Duvic M Am J Clin Dermatol; 2007; 8(1):47-50. PubMed ID: 17298107 [TBL] [Abstract][Full Text] [Related]
13. Drug-induced lupus: an update on its dermatologic aspects. Marzano AV; Vezzoli P; Crosti C Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous lupus erythematosus induced by golimumab therapy. Al Izzi M; Reda A Int J Rheum Dis; 2017 Dec; 20(12):2159-2161. PubMed ID: 27458030 [No Abstract] [Full Text] [Related]
18. Recurrent subacute cutaneous lupus erythematosus following exposure to different drugs. Liakou AI; Brunner M; Theodorakis MJ; Makrantonaki E; Zouboulis CC Acta Derm Venereol; 2011 Sep; 91(5):586-7. PubMed ID: 21597670 [No Abstract] [Full Text] [Related]
19. Drug-induced lupus erythematosus. Vedove CD; Del Giglio M; Schena D; Girolomoni G Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892 [TBL] [Abstract][Full Text] [Related]
20. A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment. Andric M; Dixit S; Robaei D; Watchorn R; Verma N Indian J Ophthalmol; 2013 Dec; 61(12):752-4. PubMed ID: 24212210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]